China Medical System Holdings Limited
CHSYFOTCHealthcare● Active
$0.93
$-0.42(-31.06%)
Market Cap$2.3B
P/E Ratio—
52W High$1.6358
52W Low$0.9307
China Medical System Holdings Limited (CHSYF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CHSYF · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $8.00B | $7.47B | $8.01B | $9.15B | $8.34B |
| Cost of Revenue | $2.28B | $2.05B | $1.94B | $2.11B | $2.09B |
| Gross Profit | $5.72B | $5.42B | $6.08B | $7.04B | $6.25B |
| Gross Margin %(computed) | 71.50% | 72.60% | 75.82% | 76.89% | 74.93% |
| Operating Expenses | |||||
| R&D Expenses | $0.57B | $0.33B | $0.20B | $0.13B | $0.11B |
| G&A Expenses | $0.00B | $0.78B | $0.66B | $0.64B | $0.44B |
| Total Operating Expenses | $4.18B | $3.69B | $3.36B | $3.39B | $3.03B |
| Operating Income | $1.54B | $1.73B | $2.71B | $3.55B | $3.15B |
| Operating Margin %(computed) | 19.22% | 23.20% | 33.85% | 38.82% | 37.79% |
| Interest Income | $0.08B | $0.13B | $0.15B | $0.11B | $0.08B |
| Interest Expense | $0.02B | $0.04B | $0.05B | $0.05B | $0.03B |
| Income Before Tax | $2.05B | $2.01B | $2.87B | $3.76B | $3.46B |
| Income Tax Expense | $0.64B | $0.40B | $0.49B | $0.49B | $0.43B |
| Net Income | $1.45B | $1.62B | $2.40B | $3.26B | $3.02B |
| Net Margin %(computed) | 18.13% | 21.69% | 29.96% | 35.62% | 36.19% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.60 | $0.67 | $0.98 | $1.33 | $1.22 |
| Wtd Avg Shares | 2.42B | 2.43B | 2.45B | 2.45B | 2.47B |
| EBITDA | $1.80B | $2.31B | $2.92B | $3.76B | $3.70B |
| EBITDA Margin %(computed) | 22.47% | 30.90% | 36.47% | 41.11% | 44.44% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · CNY · B
Explore more China Medical System Holdings Limited data
About China Medical System Holdings Limited (CHSYF) Income Statement
China Medical System Holdings Limited (CHSYF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CHSYF reported revenue of $8.00B, gross profit of $5.72B (gross margin 71.50%), and net income of $1.45B — a net profit margin of 18.13%.
Frequently asked questions
CHSYF · 4 questionsChina Medical System Holdings Limited (CHSYF) reported revenue of $8.00B for 2025, up 7.1% year-over-year.
CHSYF revenueCHSYF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08